although the non-invasive technique of high resolution Doppler ultrasound has recently been used to evaluate changes in conduit artery diameter in response to flow (generated by a downstream reactive hyperaemia) in diabetic patients [10, 11] . Zenere et al. [11] demonstrated impaired flow-induced dilatation in femoral arteries of normoalbuminuric and microalbuminuric IDDM patients, but the endothelium-dependence of this flow-response was not quantified.
The aim of the present study was to investigate flow-responses in isolated small arteries from control and streptozotocin(STZ)-diabetic rats, using the technique of perfusion myography.
Materials and methods
Induction of experimental diabetes. Diabetes was induced in male Sprague-Dawley rats (250--300 g, Bantin and Kingman Ltd., Aldbrough, Humberside, UK) by caudal intravenous injection of STZ (45 mg/kg) dissolved in citrate buffer (0.1 mol/l trisodium citrate, 0.1 mol/l citric acid). Development of diabetes was confirmed by the presence of glycosuria 72 h after injection. No attempt was made to control hyperglycaemia by insulin treatment. After 28 days, animals were killed by inhalation of CO 2 and cervical dislocation. Cardiac puncture was performed to obtain blood samples for the measurement of plasma glucose (diabetic rat plasma glucose: 43.6 ± 2.6 mmol/l, n = 8; enzymatic UV test, using a HK/G6P-DH method, Cobas Fara Centrifugal analyser, Roche Diagnostic Systems, Welwyn Garden City, Herts., UK). Control rats were housed separately from the diabetic animals and all animals were given food and water ad libitum. The body weight of diabetic animals was less than that of controls at 28 days (control 369.0 ± 7.0, n = 9 vs diabetic 276.5 ± 10.5 g, n = 8, p < 0.01). This work was approved by the British Home Office (Project License: PPL 90/ 00 764) and followed the "Principles of Laboratory Animal Care"" (NIH Publication No. 85--23, revised 1985).
Assessment of vascular function. The small intestine and intact mesentery were removed from the animal and placed in cold physiological salt solution (PSS). Branches of the mesenteric tree which run parallel to the gut wall (approximately 2 mm in length) were dissected free of connective tissue and mounted in a pressure myograph (Living Systems Instrumentation Inc., Burlington, V. T., USA). This technique has been described previously in detail [12--15] . Briefly, the vessel was cannulated on a pair of opposing glass microcannulae (cannulae tip diameter approximately 70 mm; previously matched for resistance to flow) and secured at each end with fine nylon sutures. The diameter of the cannula tip was similar to that of the vessel before being pressurised. Each vessel was orientated to the direction of flow in vitro in a similar manner to that experienced in vivo. The position of the distal cannulae was carefully adjusted to eliminate buckle, but avoiding undue stretch, of the artery. The vessel was perfused externally (5 ml/min) and intraluminally with PSS. Intraluminal flow was generated by a mini peristaltic pump and windkessels were attached on both sides of the vessel to dampen pulsatile flow. ÁIn line© pressure transducers monitored the proximal and distal pressure at each end of the vessel and a servo-controlled pump maintained the required mean intraluminal pressure. The vessel was visualized continuously by a CCD camera attached to a light microscope ( × 10) and displayed on a video monitor. The video camera was aligned so that the vessel axis was perpendicular to the horizontal scan lines, which were positioned at the same point of the artery for the duration of the experiment. Internal diameter (i.d) was measured continuously by a video dimension analyser (minimum measurable change in i.d is 1 mm), and both i. d. and pressure (proximal to the artery) recorded on a chart recorder. The artery i. d. was recorded at the end of each experimental interval.
Experimental protocol. After cannulation, the vessel was pressurised to 40 mmHg and allowed to equilibrate for 40 min (superperfused continuously with PSS). Artery viability was assessed by constriction to extraluminal application of noradrenaline (NA, 1 mmol/l) in potassium (64 mmol/l)-substituted PSS and subsequent dilatation to ACh (1 mmol/l). All successfully mounted arteries proved viable. The vessel was pressurised to 80 mmHg and i.d recorded before and after a 15 min equilibration period. The artery was then preconstricted with NA (0.1--1 mmol/l) in PSS, to achieve an approximate 40 % reduction in i. d. Once the NA-induced tone demonstrated a stable baseline, flow was initiated in incremental flow steps every 3 min (0.00--1.27 ml/s) and changes in i. d. recorded at the end of each flow step. The flow pump had been previously calibrated and the relationship between proximal pressure and flow rate found to be linear over this range. Mean intraluminal pressure was maintained 80 mmHg throughout the flow protocol by the servo-controlled pump, although occasionally it was necessary to make adjustments for small changes in proximal perfusion pressure which occurred as flow was increased. In the absence of flow, the vessel was superperfused with PSS for 10 min and then with Nw-nitro-l-arginine methyl ester (l-NAME) in PSS (0.1 mmol/l) for 20 min. The vessel was then again preconstricted with NA and the flow protocol repeated in the continuous presence of l-NAME. Reproducibility of the repeated flow response was ascertained in a separate group of arteries (maximum response to flow in first flow protocol 9.5 ± 1.8 vs second flow protocol 8.6 ± 1.7 %, n = 8 p = NS).
Calculation of wall shear stress. Wall shear stress (WSS, dyn/ cm 2 ) was calculated from the equation: 4h;Q × 10 9 /pr 3 , where h is viscosity at 37°C (poise = dyn ⋅ s
), Q is flow rate (ml/s) and r is artery internal radius (mm). The multiplication factor 10 9 corrects for the use of both ml/s for flow and mm for arterial radius (1 ml = 10 9 mm 3 ); viscosity was 0.7 centipoise. 
Results
There was no significant difference in the i. d. of arteries from control (223 ± 8 mm, n = 9) and diabetic rats (239 ± 12 mm, n = 8 ) when pressurised to 40 mmHg. After a 15 min equilibration period at 80 mmHg, the mean i. d. of arteries from the diabetic animals was slightly greater than that of controls (control 224 ± 14 vs diabetic 265 ± 12 mm, p < 0.05). Only arteries from control animals demonstrated development of tone during the 15 min period at 80 mmHg. The degree of preconstriction achieved with NA was similar between the two groups (control 54.5 ± 5.3 vs diabetic 52.8 ± 3.8 %; NS) and the i. d. of the constricted arteries were not significantly different (control 131 ± 7 vs diabetic 145 ± 11 mm).
Response to flow in arteries from controls. When pressurised to 80 mmHg, a graded increase in luminal flow was associated with dilatation in arteries from the control animals ( Figs. 1 and 2 ). Arteries dilated maximally by 13.46 ± 6.52 % of the initial preconstricted artery diameter at a flow rate of 0.79 ml/s (Fig. 2) . Wall shear stress ranged from 0.0 to 38.6 dyn/cm 2 with maximum dilatation elicited at a shear stress of 20.72 ± 3.29 dyn/cm 2 . At higher flow rates, a transient flow-induced constriction was observed.
This dilatation to flow was inhibited by preincubation of arteries with the NO synthase inhibitor l-NAME, and the flow stimulus led to a significant vasoconstriction (Fig. 2 , control summary measure 10.46 ± 3.24 vs control + l-NAME --9.69 ± 4.70, p < 0.005). l-NAME reduced artery diameter in vessels before preconstriction with NA (% change in i. d. --9.88 ± 5.04), but this response did not achieve significance.
Response to flow in arteries from diabetic animals. In contrast to arteries from control rats, arteries from diabetic animals did not dilate to flow, indeed the same flow stimulus that evoked a dilatation in control arteries elicited a significant vasoconstriction in the arteries from diabetic animals (% change in diameter at a flow rate of 0.79 ml/s, --7.44 ± 3.38, n = 8; summary measure for controls 10.46 ± 3.24 vs diabetics --6.82 ± 3.10, p < 0.005, Fig. 2 ). The degree of vasoconstriction to flow was similar to that observed in a Fig. 1 a,b . Representative traces to demonstrate the changes in internal diameter in response to incremental increases in flow (0--1.27 ml/s) in 5th order mesenteric arteries preconstricted with NA from: a) control and b) diabetic rat. Arteries were pressurised to 80 mmHg and the intraluminal pressure gradient was maintained throughout the flow protocol b the control arteries when in the presence of l-NAME. There was no significant effect of l-NAME on the response of arteries from diabetic animals to flow (summary measure: diabetic --6.82 ± 3.10 vs diabetic + l-NAME 2.27 ± 5.31) or on basal tone (% change in i. d. --5.24 ± 3.25).
The shear stress values generated by flow were variable and numerically greater in arteries from diabetic animals (range 0.00--65.76 ± 28.32 dyn/cm 2 ) but this difference did not achieve statistical significance. The relation between shear stress and subsequent change in artery i. d. (Fig. 3) clearly reflects the insensitivity of arteries from diabetic animals to the shear stimulus.
Discussion
This study clearly demonstrates that flow elicits a significant vasodilatation in preconstricted resistance arteries from control male Sprague-Dawley rats, a response that is dependent on NO. In contrast, arteries of the STZ-diabetic rat exhibit an impaired response to flow, indeed these arteries constricted to the same flow stimulus.
Flow-induced dilatation has been studied extensively in conduit and cerebral arteries both in vivo and in vitro [9, 17--21] . There are fewer studies of this phenomenon in the resistance vasculature, although flow-induced dilatation has been observed in small mesenteric arteries in vivo [22] , isolated small mesenteric arteries from pregnant rats [14] , resistance sized arteries from rat skeletal muscle [23--25] , rabbit ear arteries [26] and small coronary vessels [27] . The maximum flow-induced dilatation has varied greatly between studies, an observation which may reflect variation among arteries to develop and maintain spontaneous tone. Thus, mesenteric arteries are reported to develop 14 % tone at an intraluminal pressure of 80 mmHg [14] whereas gracilis arteries (which exhibit greater vasodilatation) develop approximately 60 % myogenic tone [23] . The dependence of flow responses on tone has also been reported in studies of rabbit ear arteries [26] and rat skeletal arteries [25] , the greater the initial tone, the more pronounced the subsequent flow-induced dilatation. Smaller arteries generally develop greater myogenic constriction to pressure and the diversity of reports among Áresistance© sized arteries may also reflect the choice of diameter of the artery studied.
In the present study, arteries were preconstricted with NA to ensure a reproducible degree of wall tone throughout the experimental protocol. The magnitude of the dilatation elicited by flow in these preconstricted control arteries (13.4 %) was comparable to that observed in non-preconstricted rat cerebral arteries [21] and mesenteric arteries from pregnant rats [14] . The response to flow was biphasic, vessels dilated at low flow rates but at higher flow rates there was a tendency for vessel diameter to decrease. This phenomenon has been observed in other vessels [21] and it can be speculated that, at increased flow rates, vessels would resist further increases in diameter and constrict towards a Áset© point diameter, a response which would in vivo be a protective mechanism to prevent over perfusion of the end organ. The Responses to flow in preconstricted small mesenteric arteries from control rats (R, in PSS, and A in the presence of 0.1 mmol/l l-NAME, n = 9), and STZ diabetic rats (U, n = 8). Intraluminal flow was increased, in incremental steps, every 3 mins, from 0--1.27 ml/s and intraluminal pressure maintained at 80 mmHg throughout the flow protocol.
* P < 0.005 compared to arteries from controls Fig. 3 . Shear stress-associated changes in internal diameter. Relation between shear stress and percentage change in i. d. in response to an increasing flow stimulus in mesenteric arteries from control (R, n = 9) and STZ-diabetic Sprague-Dawley rats (U, n = 8). Shear stress was calculated using the equation described in the methods section maximum flow-induced dilatation in arteries from controls occurred at levels of shear stress that were comparable to those calculated from the measurement of erythrocyte velocity in arteries in situ [28] . The levels of flow, however, required to achieve physiological levels of shear stress were greater than those seen in vivo due to differences in the viscosity of PSS compared to that of whole blood.
Endothelium-dependence of flow-mediated dilatation has been demonstrated in most [14, 21, 23, 24, 29] but not all [18] arteries studied. In this study, dilatation was predominantly NO-mediated, as the response was abolished by the NO synthase inhibitor, l-NAME. This is in agreement with previous studies from our laboratory which showed that dilatation in mesenteric arteries from pregnant rats was also inhibited by l-NAME [14] and endothelium removal [30] , but contrasts with skeletal muscle arteries [23] in which flow-induced dilatation was mediated by both NO and prostacylin.
It is of interest that inhibition of NO synthase evoked profound flow-induced vasoconstriction. This suggests that there may be a co-release of vasoconstrictors and vasodilators in response to flow. Endothelin, a potent vasoconstrictor has been shown, in some studies [31, 32] but not all [33] to be released by the endothelial cell layer in response to increasing flow and hence shear stress and is therefore a potential candidate mediator of the response. Vasoconstrictor prostanoids such as thromboxane have also been implicated in flow-induced vasoconstriction [34] . However, Bevan and Joyce [26] have reported flow-induced constriction in rabbit ear arteries which is not endothelium-dependent and may suggest a direct effect of flow on vascular smooth muscle tone.
The vasoconstriction observed in arteries from diabetic animals, and the lack of effect of l-NAME suggest that the abnormal response to flow is due to an impairment of the NO pathway. This does not necessarily imply that the ability to synthesize or release NO is compromised per se, but could be an indication of decreased sensitivity of the underlying smooth muscle for NO, increased NO breakdown or a specific disruption of shear stress-NO signal transduction mechanisms [3] . It is unlikely that the impaired flow response can be explained by an alteration of smooth muscle sensitivity to NO, as parallel studies performed in arteries from a group of diabetic and control animals (using wire myography) did not show any impairment of the response to the endothelium independent vasodilator, sodium nitroprusside [35] . A more likely explanation is that there is increased NO breakdown or quench due to increased superoxide generation or the presence of advanced glycosylation end products, both of which can scavenge NO on release from the endothelium [3] . While the structural integrity of the vascular endothelium is maintained in rats with diabetes of 4 weeks© duration [36] , there may be specific impairment of signal transduction pathways. This has been suggested by previous investigations of vascular function in human diabetic patients [6] and the STZ-diabetic rat [7] , in which vasodilatation to ACh, but not bradykinin, is impaired. Although originally suggested that flow-mediated dilatation occurs via a G i protein [37] , a recent report has suggested that flow stimulates the phosphorylation of both G i and G q proteins [38] . Specific disruption of the G i protein pathway, therefore, may not be inferred from the observed attenuation of flow-induced dilatation.
The observation of impaired flow-induced dilatation in arteries from diabetic arteries contrasts with the only other study of small arteries in the STZ-diabetic rat. Fujii et al. [19] , despite finding abnormal vasodilatation to ACh, reported normal flow-induced dilatation in the basilar artery measured in vivo using a cranial window in anaesthetized rats with diabetes of 6 months© duration. However, the response to flow in these cerebral arteries was shown not to be dependent on production of NO or cyclooxygenase activity [18] . While contrasting with these observations in the rat cerebral circulation, our data agree with the observations of Zenere et al [11] , who demonstrated an attenuated dilatation to flow in the femoral artery of normoalbuminuric IDDM patients, and vasoconstriction in IDDM patients with microalbuminuria.
Although myogenic tone development was not formally assessed in this study, it is interesting to note that the diabetic arteries failed to constrict to an increase in intraluminal pressure from 40 to 80 mmHg. This is in agreement with a study by Hill and Ege [39] , in which a reduction in myogenic tone development was reported in isolated skeletal muscle arteries from the STZ rat. It could be speculated that reduced myogenic tone development might account for poor flow-induced dilatation in arteries from the diabetic animals, as there may be little basal tone upon which dilatory stimuli may act. However, in this study, the initial tone was similar in both groups as the arteries were preconstricted with noradrenaline and the arteries from diabetic animals failed to dilate in response to flow. Indeed, this may relate to the situation in vivo as most arteries have some sympathetic tone superimposed upon basal myogenic tone.
In summary, this study has demonstrated that arteries from an animal model of IDDM, unlike those from controls, vasoconstrict to a flow stimulus. An absence of the normal flow response could contribute to decreased blood flow in the microvasculature associated with the long-term vascular complications of diabetes. Further investigations are required to determine whether abnormal NO-mediated flow-induced dilatation is due to an increase in scavenge of NO or an impairment of the signal transduction pathways involved in shear stress-mediated NO synthesis.
